# GEFITINIB
> **ANDA208913** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2023-04-26
## Drug
- **FDA Application Number:** ANDA208913
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GEFITINIB
- **Generic name:** GEFITINIB
- **Active ingredients:** GEFITINIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ACTAVIS LABS FL INC
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2023-04-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208913)
---
*AI Analytics · CC0 1.0*